Results 181 to 190 of about 13,239,682 (316)

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Editorial: Precision medicine in viral hepatitis: progress and prospects towards elimination

Frontiers in Cellular and Infection Microbiology
Amanda Fernández-Rodríguez, Amanda Fernández-Rodríguez, Pamela Valva   +2 more
doaj   +1 more source

Reprogramming of the hepatic ubiquitin‑immune axis: A unifying mechanism in liver disease progression (Review). [PDF]

Mol Med Rep
Ju Y, Chong X, Ning W, Shi Y, Li Y, Shi Y.   +5 more
europepmc   +1 more source

To Progress or Not to Progress, That Is the Question! Progression in Fibrotic Interstitial Lung Disease

American Journal of Respiratory and Critical Care Medicine, 2023
openaire   +2 more sources

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

Progressive Disease [PDF]

, 2020
openaire   +1 more source

Translating whole‐genome doubling into precision medicine in cancer

Molecular Oncology, EarlyView.
Whole‐genome doubling creates a WGD‐positive tumor state characterized by persistent chromosomal instability, karyotypic diversification, and cellular stress. These same biological pressures drive aggressive tumor evolution while exposing therapeutic vulnerabilities, providing a rationale for WGD‐informed precision medicine. Whole‐genome doubling (WGD)
Sejung Lee, Junghyeok Lim, Jinhyuk Bhin
wiley   +1 more source

Editorial: Modifiable risk factors for chronic kidney disease progression. [PDF]

Front Endocrinol (Lausanne)
Musto S, Secondulfo C, Migliarino S, Izzo C.   +3 more
europepmc   +1 more source

Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology

Molecular Oncology, EarlyView.
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley   +1 more source

Plasma proteomics stratification identifies phospholamban R14del carriers at risk for disease progression. [PDF]

Cardiovasc Res
Deiman FE, Arslan T, de Brouwer R, Henry I, Löfgren L, Cavallin A, Michopoulos F, Nilsson R, Henricsson M, Ahlstrom C, Davidsson P, Bomer N, Grote Beverborg N, van der Meer P.   +13 more
europepmc   +1 more source